| Members |
targetComponentId |
| Abnormal prolactin |
Abnormal prolactin (finding) |
| Abnormal protein hormone |
Abnormal protein hormone (finding) |
| onormal indragning |
Retracted structure (morphologic abnormality) |
| Abnormal secretin |
Abnormal secretin |
| Abnormal serotonin |
Abnormal serotonin |
| Abnormal steroid hormone |
Abnormal steroid hormone (finding) |
| Abnormal testosterone |
Abnormal testosterone |
| Abnormal thyroid hormone |
Abnormal thyroid hormone |
| Abnormal thyroxine |
Abnormal thyroxine |
| Abnormal triiodothyronine |
Abnormal triiodothyronine |
| Abnormal uterine contraction |
Abnormality of forces of labor |
| Abnormal vanillylmandelic acid |
Abnormal vanillylmandelic acid |
| abobotulinumtoxin A, 500 enheter, för injektion |
AbobotulinumtoxinA 500 unit powder for solution for injection vial |
| Abortion: [illegally induced] or [criminal] or [self-induced] |
Induced termination of pregnancy (procedure) |
| Above average intellect (observable entity) |
Above average intellect |
| Abscess of other specified subcutaneous tissue site |
Abscess of skin and/or subcutaneous tissue (disorder) |
| Absence of ejaculation |
Absence of ejaculation |
| absensanfall med atoniska komponenter |
Absence seizure |
| absensanfall med automatismer |
Absence seizure |
| absensanfall med autonoma komponenter |
Absence seizure |
| absensanfall med nedsättning endast av medvetandet |
Absence seizure |
| absensanfall med måttliga kloniska komponenter |
Absence seizure |
| absensanfall med toniska komponenter |
Absence seizure |
| Absidia lichtheimii |
Lichtheimia corymbifera (organism) |
| Absidia ramosa |
Lichtheimia corymbifera (organism) |
| absolut impotens |
Absolute erectile dysfunction |
| missbruk av örtmedicin eller huskur |
Substance abuse |
| missbruk av substanser som ej är beroendeframkallande |
Substance abuse |
| missbruk av steroider |
Abuse of steroid hormone |
| Acamprosate calcium |
Product containing acamprosate (medicinal product) |
| Acanthocheilonema perstans infection |
Infection by Mansonella perstans |
| Accelerated essential hypertension |
Malignant essential hypertension (disorder) |
| Accelerated secondary hypertension |
Malignant secondary hypertension |
| Accessory auricle of ear |
Polyotia |
| Accident due to other cause, NOS |
Accidental event (event) |
| Accident unspecified |
Accidental event (event) |
| oavsiktlig och/eller traumatisk tatuering |
Iatrogenic tattoo |
| oavsiktlig överdos av disulfiram |
Accidental disulfiram overdose (disorder) |
| oavsiktlig disulfiramförgiftning |
Accidental disulfiram poisoning (disorder) |
| Accidental chlorprothixene overdose |
Accidental chlorprothixene overdose (disorder) |
| oavsiktligt skärsår, punktion, perforation eller blödning under njurdialys |
Accidental cut, puncture, perforation or hemorrhage during kidney dialysis |
| Accidental decapitation NOS |
Decapitation |
| olycksfallsskada, morfologi |
Accidental injury |
| oavsiktlig överdos av natriumvalproat |
Accidental valproate overdose (disorder) |
| Accidental pesticide product overdose |
Accidental pesticide product poisoning |
| Accidental poisoning by butryophenone-based tranquilizers NOS (disorder) |
Accidental poisoning caused by butyrophenone-based tranquilizer (disorder) |
| oavsiktlig förgiftning orsakad av cabromalderivat |
Accidental poisoning caused by carbromal |
| oavsiktlig endrinförgiftning |
Accidental poisoning caused by endrin |
| oavsiktlig fenylsulftionförgiftning |
Accidental poisoning by insecticides of organophosphorus compounds |
| oavsiktlig punktion och/eller laceration under en åtgärd på ett organ |
Accidental puncture of organ during a procedure (disorder) |
| oavsiktlig överdos av natriumfusidat |
Fusidic acid overdose |
| Accidental zuclopenthixol overdose |
Accidental chlorprothixene overdose (disorder) |
| Accidentally mangled NOS |
Accidental injury |
| Accidents NOS |
Accidental event (event) |
| Acebutolol hydrochloride 100 gram powder |
Acebutolol (as acebutolol hydrochloride) 100 mg oral capsule |
| Acebutolol hydrochloride 200mg capsule |
Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) |
| acetaminofen + klorfeniraminmaleat + fenylefrinhydroklorid 500 mg/8 mg/40 mg, kapseltablett |
Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) |
| Acetaminophen + hydrocodone bitartrate 500mg/7.5mg elixir |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
| paracetamol 500 mg + orfenadrincitrat 50 mg, kapseltablett |
Orphenadrine and paracetamol only product |
| paracetamol 1000 mg/100 ml, infusionsvätska, lösning |
Product containing precisely paracetamol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| paracetamol 160 mg/5 ml, elixir |
Paracetamol 32 mg/mL oral solution |
| paracetamol 1g/dospåse, pulver |
Paracetamol only product |
| paracetamol 325 mg/15 ml + hydrokodon 10 mg/15 ml, oral lösning |
Product containing only paracetamol in oral dose form (medicinal product form) |
| paracetamol 325 mg/15 ml + hydrokodon 7,5 mg/15 ml, oral lösning |
Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution |
| paracetamol 500 mg/15 ml + hydrokodon 5 mg/15 ml, oral lösning |
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
| paracetamol 500 mg/15 ml + hydrokodon 7,5 mg/15 ml, oral lösning |
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) |
| paracetamol 80 mg/0,8 ml, droppar |
Paracetamol 100 mg/mL oral solution |
| paracetamol 80 mg/2,5 ml, elixir |
Paracetamol 32 mg/mL oral solution |
| paracetamol 80 mg/5 ml, elixir |
Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) |
| onormal paracetamolhalt |
Acetaminophen above therapeutic range |
| normal paracetamolhalt |
Acetaminophen within therapeutic range |
| paracetamol 325 mg + dextropropoxifenhydroklorid 32,5 mg per 5 ml, oral suspension |
Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) |
| paracetamol 325 mg + dextropropoxifenhydroklorid 32,5 mg/5 ml, sockerfri suspension |
Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) |
| Acetaminophen+diphenhydramine hydrochloride |
Product containing diphenhydramine and paracetamol (medicinal product) |
| acetazolamid 500 mg, kapsel med modifierad frisättning |
Acetazolamide only product in oral dose form |
| Acetazolamide 500mg m/r capsule |
Acetazolamide only product in oral dose form |
| acetazolamid 500 mg, depåkapsel |
Acetazolamide only product in oral dose form |
| Acetic acid + turpentine |
Product containing acetic acid and turpentine oil (medicinal product) |
| Acetic acid 2% |
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) |
| Acetic acid 2% solution |
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) |
| ättiksyra, koncentrerad + hydrokortison 2 % volym per volym/1 % vikt per volym, lösning |
Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug) |
| koncentrerad ättiksyra 0,9 vikt-% + oxikinolinsulfat 0,025 vikt-% |
Acetic acid 9 mg/g and oxyquinoline (as oxyquinoline sulfate) 250 microgram/g vaginal gel |
| ättiksyra, koncentrerad, 2 %, lösning |
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug) |
| Acetobacter liquefaciens |
Gluconacetobacter liquefaciens (organism) |
| Acetyl carbromal |
Acetylcarbromal |
| acetylerade ullfettalkoholer |
Wool alcohol |
| acetylkolinklorid 1 %, sköljvätska för intraokulärt bruk |
Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Acetylcholine chloride 20mg |
Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| acetylkolinklorid 20 mg, intraokulär lösning, flaska |
Product containing only acetylcholine in parenteral dose form (medicinal product form) |
| acetylkolinklorid 20 mg, flaska med intraokulär lösning + spädningsvätska |
Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| biverkning av acetylkolinklorid |
Adverse reaction to acetylcholine (disorder) |
| acetylkolinkloridallergi |
Allergy to acetylcholine (finding) |
| acetylcystein 200 mg/ml infusionsvätska, lösning, ampull 30 ml |
Acetylcysteine 200 mg/mL solution for injection |
| Acholeplasma florum |
Mesoplasma florum |
| Achromobacter xylosoxidans xylosoxidans |
Achromobacter xylosoxidans (organism) |
| aciklovir 25 mg/ml, infusionsvätska, lösning, flaska 20 ml |
Product containing precisely aciclovir (as aciclovir sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| aciklovir 25 mg/ml, infusionsvätska, lösning, flaska 40 ml |
Product containing precisely aciclovir (as aciclovir sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| aciklovir 25 mg/ml, infusionsvätska, lösning, flaska 10 ml |
Product containing precisely aciclovir (as aciclovir sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Acid lipase deficiency |
Wolman's disease |
| Acid reflux &/or oesophagitis |
Gastro-esophageal reflux disease with esophagitis |
| Acid-aminoacid ligase |
Acid-aminoacid ligase |
FHIR